Counterforce Health (Page 116)

More issues

Myths vs. Facts: Getting Vanflyta (quizartinib) Covered by Cigna in Virginia

Quick Answer: To get Vanflyta (quizartinib) covered by Cigna in Virginia, you need documented FLT3-ITD positive AML, age ≥18, and evidence you've tried preferred alternatives like midostaurin first. If denied, Virginia's external review process through the State Corporation Commission gives you a second chance—with 60-76%

How to Get Cabometyx (Cabozantinib) Covered by Humana in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cabometyx Covered by Humana in Pennsylvania Cabometyx requires prior authorization from Humana as a Tier 5 specialty drug. Your oncologist must submit comprehensive documentation including diagnosis, staging, prior treatments, and NCCN guideline justification. If denied, Pennsylvania's Independent External Review Program overturns approximately 50% of appeals.

How to Get Thiola / Thiola EC (Tiopronin) Covered by Blue Cross Blue Shield in Ohio: Appeals, Timelines, and State Protections

Quick Answer: Getting Thiola Covered in Ohio Blue Cross Blue Shield Ohio covers Thiola/Thiola EC for severe homozygous cystinuria when strict prior authorization criteria are met. Key requirements: age ≥9 years, documented cystine stones, failed conservative therapy (hydration, alkalinization), and specialist involvement. If denied, you have 180 days to

How to Get Filsuvez Covered by UnitedHealthcare in Texas: Complete Prior Authorization Guide with Forms and Appeal Scripts

Answer Box: Getting Filsuvez Covered by UnitedHealthcare in Texas Filsuvez requires prior authorization from UnitedHealthcare for epidermolysis bullosa treatment in Texas. Your fastest path to approval: (1) Confirm your diagnosis is dystrophic or junctional EB with genetic testing, (2) Document wound size (10-50 cm²) and duration (3+ weeks), and (3)

How Long Does It Take to Get Ultomiris (ravulizumab) Approved by Humana in North Carolina? Complete Timeline Guide

Quick Answer: Humana typically approves complete Ultomiris prior authorizations within 1 business day for electronic submissions, but missing REMS enrollment or vaccination records can delay approval by weeks. Start by ensuring your prescriber is enrolled in the UltSolREMS program and you've received both MenACWY and MenB vaccines at

Do You Qualify for Brineura (Cerliponase Alfa) Coverage by Humana in Florida? Decision Tree & Next Steps

Answer Box: Your Path to Brineura Coverage Likely eligible if: Your child is ≥3 years old with confirmed CLN2 disease (both enzyme deficiency and genetic testing), has mild-to-moderate symptoms with some remaining motor and language function, and can receive treatment at a specialized center with intraventricular device placement capabilities. Fastest

Myths vs. Facts: Getting Gilenya (fingolimod) Covered by UnitedHealthcare in New York

Answer Box: Getting Gilenya Covered by UnitedHealthcare in New York Bottom line: UnitedHealthcare requires prior authorization and step therapy for Gilenya (fingolimod), but coverage is achievable with proper documentation. Most denials stem from missing baseline tests (EKG, eye exam), incomplete step therapy records, or inadequate medical necessity documentation. Fastest path:

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by UnitedHealthcare in Illinois: Complete Prior Authorization Guide

Quick Answer: Getting Xywav Covered in Illinois UnitedHealthcare requires prior authorization for Xywav with step therapy requirements. Your fastest path: 1) Enroll in the mandatory REMS program, 2) Document failed trials with preferred alternatives like Xyrem, 3) Submit complete OptumRx prior authorization form with sleep study results and ICD-10 codes

How to Get Aldurazyme (Laronidase) Covered by Blue Cross Blue Shield in North Carolina: Complete Appeals Guide with Forms and Deadlines

Answer Box: Getting Aldurazyme Covered by Blue Cross Blue Shield in North Carolina Aldurazyme (laronidase) requires prior authorization from Blue Cross Blue Shield of North Carolina. Success depends on documented MPS I diagnosis via enzymatic testing and genetic confirmation. If denied, you have 120 days to file an external review

How to Get Tysabri (Natalizumab) Covered by Humana in Pennsylvania: Appeals Guide with Templates

Quick Answer: Getting Tysabri Covered by Humana in Pennsylvania If Humana denied your Tysabri (natalizumab) coverage, you have options. First step: Ensure TOUCH program enrollment for both patient and prescriber—this is mandatory. Fastest path: Submit a formulary exception with medical necessity documentation showing failed DMTs and contraindications to alternatives.